{"id":50208,"date":"2023-03-29T08:44:04","date_gmt":"2023-03-29T08:44:04","guid":{"rendered":"https:\/\/dailytalks.org\/?p=50208"},"modified":"2023-03-29T08:44:04","modified_gmt":"2023-03-29T08:44:04","slug":"biocortex-raises-5-million-in-funding-led-by-sofinnova-partners-and-hoxton-ventures-to-unlock-drug-bacteria-interactions","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=50208","title":{"rendered":"BioCorteX Raises $5 Million in Funding Led by Sofinnova Partners and Hoxton Ventures To Unlock Drug-Bacteria Interactions"},"content":{"rendered":"<p>The company is developing precision medicine solutions using in silico simulation to solve the complex relationship bacteria, viruses and fungi play in health, disease and drug responseEdward Kliphuis, Partner at Sofinnova Partners, and Hussein Kanji, Partner, Hoxton Ventures, join the BioCorteX Board of DirectorsLONDON, UK \/ ACCESSWIRE \/ March 28&#8230;<br \/><a href=\"https:\/\/www.accesswire.com\/viewarticle.aspx?id=746100&#038;lang=en\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>The company is developing precision medicine solutions using in silico simulation to solve the complex<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[],"class_list":["post-50208","post","type-post","status-publish","format-standard","hentry","category-health"],"featured_image_urls":{"full":"","thumbnail":"","medium":"","medium_large":"","large":"","1536x1536":"","2048x2048":"","chromenews-featured":"","chromenews-large":"","chromenews-medium":""},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=43\" rel=\"category\">Health<\/a>","tag_info":"Health","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/50208","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=50208"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/50208\/revisions"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=50208"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=50208"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=50208"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}